Company page

Delcath Systems, Inc.

Delcath Systems, Inc. (Ticker: DCTH) is a public company operating in the American market with a market capitalization of approximately $403.6 million. The company focuses on developing innovative therapies for the treatment of cancer. Delcath is dedicated to improving patient outcomes through its specialized medical technologies.